Rivastigmine in apathetic but dementia and depression-free patients with Parkinson’s disease: a double-blind, placebo-controlled, randomised clinical trial - Devos, D; Moreau, C; Maltete, D (J Neurol Neurosurg Psychiatry, 2014)
et al.